PharmaBoardroom

Management in the Age of Confinement

With the global coronavirus pandemic still ongoing and teleworking having become the new normal, pharma executives from across the world are giving us…

Jingsong Wang – Chairman & CEO, Harbour BioMed, China

PharmaBoardroom caught up with Dr Jingsong Wang, chairman & CEO of Harbour BioMed to discuss the exciting clinical and commercial milestones of…

China’s Regulatory Reform and its Contribution to Global…

Song Ruilin, chairman of the China Pharmaceutical Innovation and Research Development Association (PhIRDA) highlights the leaps and bounds with which…

Roche CEO Severin Schwan on Importance of Supply Chain,…

During a global virtual press briefing on 19 March 2020, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)…

Roche’s Coronavirus Test Gets FDA Emergency Use…

Over the past few years, innovative Swiss giant Roche has combined its position as the world’s number 1 biotech company and its strength in in vitro…

China’s Clover Biopharmaceuticals Partners with GSK on…

Chinese biotech Clover Biopharmaceuticals may have flown under the radar thus far but it has stepped into the global limelight recently by partnering…

China: A New Decade

2019 was a landmark year for the Chinese healthcare industry.* Since the publication of the ‘Healthy China 2030’ blueprint in 2016 by the Chinese…

Bing Xu – General Manager, Vital River Laboratories, China

Bing Xu, GM of Vital River Laboratories, shares the company’s development in the last 20 years; the challenges of advantages of their JV with…

Indian Pharma Supply Chain Hit by Coronavirus Outbreak

The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions for Indian pharma manufacturers and…